Catherine Skari
-
Sep- 2023 -27 SeptemberScientific Literature
The Danish National Haemoglobinopathy Screening Programme: Report From 16 Years of Screening in a Low-prevalence, Non-endemic Region
The Danish national haemoglobinopathy screening programme seeks to determine parental haemoglobinopathy carrier state antenatally. In this retrospective register based study,…
Read More » -
27 SeptemberScientific Literature
Analysis of the Pregnancy Status and Outcomes of Pregnant Women with α-Thalassemia: A Retrospective Clinical Study
Background: The prevalence of α-thalassemia is high in Guangxi, and its co-occurrence with pregnancy may impede maternal system functions, with…
Read More » -
23 SeptemberTIF News
WEBINAR | Official Launch of TIF’s Nutrition Guidelines in Thalassaemia and PKD
This essential guide has been eagerly awaited by healthcare professionals and patients alike, and we are pleased to invite you…
Read More » -
22 SeptemberNews
BLOOD TRAΝSFUSION THERAPY | FDA Approves Hemanext ONE®
This revolutionary technology sets a new standard in RBC processing and storage by limiting oxygen in the storage environment, thereby…
Read More » -
15 SeptemberScientific Literature
How I Τreat Non-Transfusion-Dependent β-Thalassemia
The intricate interplay of anemia and iron overload under the pathophysiological umbrella of ineffective erythropoiesis in non-transfusion-dependent β-thalassemia (NTDT) results…
Read More » -
14 SeptemberNews
WEBINAR | Haemoglobin Disorders and EU Health Policies, 21 September 2023
Designed for patients and their families, these webinars aim to foster national advocacy for the improvement of service delivery. The…
Read More » -
10 SeptemberScientific News
Corticosteroid Use in Pregnant Women with SCD Doubles Risk of Severe VOCs
According to a French study, corticosteroids used during pregnancy are a risk factor for more severe vaso-occlusive crises (VOCs) in…
Read More » -
1 SeptemberNews
CLINICAL NEWS | FDA Approves Luspatercept for First-line Treatment of Anemia in Lower-Risk MDS
The approval was based on interim results from the pivotal phase 3 COMMANDS trial (ClinicalTrials.gov Identifier: NCT03682536) that evaluated the efficacy…
Read More » -
Aug- 2023 -30 AugustNews
TIF European Health Policy Webinar Series | 21 September 2023
Designed for patients and their families, these webinars aim to foster national advocacy for the improvement of service delivery. The…
Read More » -
27 AugustTIF News
PUBLICATIONS | Nutrition Guidelines in Thalassemia & PKD
Nutrition holds a significant position in the lives of individuals afflicted with thalassaemia and other hereditary anaemias. As part of…
Read More »
